explore -WSS

explore

author：explore 2025-09-27 12:56:07 - browse：82

Two researchers look at a projection screen displaying medical devices, scientific graphs and DNA — health tech coverage from STAT — Adobe

The federal government’s plan to boost its oversight of the use of artificial intelligence tools in health care drew censure from startups arguing that overregulation stifles new ideas. But as Washington forges ahead, founders say they’re in the dark about who will be regulated and how — and they’re urging policymakers to offer clarity.

As they race for a slice of the $4 trillion U.S. health care market, AI founders and investors say regulatory uncertainty is a hurdle, forcing them to build more slowly and meticulously document for fear of potential audits. That makes it harder to keep up with the tech industry’s breakneck pace, they tell STAT.

The regulatory uncertainty adds to the many challenges dogging young health tech ventures today: Last year investments in digital health startups shriveled to their lowest annual total since 2019, and leaders are desperate to preserve what little funds they have, including through layoffs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Schizophrenia gene found to be linked to cells' energy dysfunction

focus

WSS

Novo Nordisk touts Wegovy study, but still struggling with supply

Biden administration begins canceling student loan debt for 804,000 borrowers

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Morgan Health, with ambitious aims, wants you to know it’s still here

Timeline: How the deadly wildfires took over Maui day by day

3 medical device trends to watch in 2024

explore

explore

explore

Apple is now the first public company to be valued at $3 trillion

After Optum profits sink, UnitedHealth makes changes

The high cost of giving birth even with insurance

Senators push IRS to launch nonprofit hospital probe

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

What does generative AI mean for health care? We asked experts

JPM: CVS says Medicare Advantage patients are impacting profits

The high cost of giving birth even with insurance

Burning questions for the 2024 JPM Healthcare Conference

knowledge

Dozens dead from Maui wildfires: What we know about the victims

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

UCB departs biotech trade group BIO

Aspartame and sugar

The biotech scorecard for Q1: 17 stock

explore

focus

focus

knowledge